This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA284344; GEO: GSE69029 |
| Type | Umbrella project |
| Publications | Terragna C et al., "The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD).", Oncotarget, 2016 Mar 1;7(9):9666-79 |
| Submission | Registration date: 19-May-2015
Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology "L.A.Serà gnoli" |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 28282578 |
| Data volume, Processed Mbytes | 1179 |
| Data volume, Supplementary Mbytes | 1509 |
CD138+ expression and genomic profile obtained from newly diagnosed Multiple Myeloma patients up-front treated with VTD induction therapy encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA283982 | Homo sapiens | Expression data from BM-CD138+, obtained from newly diagnosed Multiple Myeloma patients [response to VTD therapy] (Department of Experimental,...) |
|
| Variation | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA284348 | Homo sapiens | Affymetrix SNP array data from BM-CD138+, obtained from newly diagnosed Multiple Myeloma patients [response to VTD therapy] (Department of Experimental,...) |
|